- Published at
- by benzinga.com
mixed
mixed
Mega Genomics Eyes Hong Kong IPO To Ride Growing Popularity of Genetic Testing
Key Takeaways: Mega Genomics is looking to list about 11.9 million shares at HK$18-HK$22 apiece in Hong Kong on June 23 Although the company’s net profit didn’t grow last year amid pressure on margins, it remained profitable unlike listed competitors New Horizon Health and Burning Rock Biotech By Molly Wen